occupancy in patients with recent-onset schizophrenia treated
with low-dose olanzapine or haloperidol: a randomized, doubleblind study. Am J Psychiatry 160: 303–309.
Efron B (1982). The Jackknife, the Bootstrap and Other Resampling
Plans. SIAM: Bristol.
Farde L, Nordstrom AL, Wiesel FA, Pauli S, Halldin C, Sedvall G
(1992). Positron emission tomographic analysis of central D1
and D2 dopamine receptor occupancy in patients treated with
classical neuroleptics and clozapine. Relation to extrapyramidal
side effects. Arch Gen Psychiatry 49: 538–544.
Farde L, Suhara T, Nyberg S, Karlsson P, Nakashima Y, Hietala J
et al (1997). A PET-study of [11C]FLB 457 binding to
extrastriatal D2-dopamine receptors in healthy subjects and
antipsychotic drug-treated patients. Psychopharmacology (Berlin)
133: 396–404.
Guy W (1976). Clinical Global Impression. US Department of
Health, Education, and Welfare, Public Health Service, Alcohol,
Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural
Research Programs: Rockville, MD.
Haber SN (2003). The primate basal ganglia: parallel and
integrative networks. J Chem Neuroanat 26: 317–330.
Hall H, Farde L, Halldin C, Hurd YL, Pauli S, Sedvall G (1996).
Autoradiographic localization of extrastriatal D2-dopamine
receptors in the human brain using [125I]epidepride. Synapse
23: 115–123.
Houle S, Kapur S, Hussey D, Jones C, DaSilva J, Wilson A (1996).
Measurment of [11C]-raclopride binding using a bolus plus
infusion protocol. In: Myers R, Cunningham V, Bailey DL,
Jones T (eds). Quantification of Brain Function Using PET.
Academic Press: San-Diego.
Joel D, Weiner I (2000). The connections of the dopaminergic
system with the striatum in rats and primates: an analysis with
respect to the functional and compartmental organization of the
striatum. Neuroscience 96: 451–474.
Kapur S, Remington G, Jones C, Wilson A, DaSilva J, Houle S et al
(1996). High levels of dopamine D2 receptor occupancy with
low-dose haloperidol treatment: a PET study. Am J Psychiatry
153: 948–950.
Kapur S, Zipursky R, Jones C, Remington G, Houle S (2000).
Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode
schizophrenia. Am J Psychiatry 157: 514–520.
Kapur S, Zipursky RB, Remington G (1999). Clinical and
theoretical implications of 5-HT2 and D2 receptor occupancy
of clozapine, risperidone, and olanzapine in schizophrenia. Am J
Psychiatry 156: 286–293.
Kapur S, Zipursky R, Roy P, Jones C, Remington G, Reed K et al
(1997). The relationship between D2 receptor occupancy and
plasma levels on low dose oral haloperidol: a PET study.
Psychopharmacology (Berlin) 131: 148–152.
Kapur S, Zipursky RB, Remington G, Jones C, DaSilva J,
Wilson AA et al (1998). 5-HT2 and D2 receptor occupancy of
olanzapine in schizophrenia: a PET investigation. Am J
Psychiatry 155: 921–928.
Kay SR, Fiszbein A, Opler LA (1987). The positive and negative
syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:
261–276.
Kessler R, Ansar AS, Lui R, Dawant B, Meltzer H (2003).
Occupancy of cortical and substantia Nigra DA D2 receptors
by typical and atypical antipsychotic drugs. Schizophr Res 60:
242–243.
